← FDA Drug Approvals (Drugs@FDA)
DUPIXENT
BLA · Biologics License Application · Sponsor: REGENERON PHARMACEUTICALS · Approved 2017-03-28
Drug application
- FDA Application #
BLA761055- Application type
- Biologics License Application
- Brand name
- DUPIXENT
- Generic name
- DUPILUMAB
- Active ingredients
- DUPILUMAB
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- REGENERON PHARMACEUTICALS
- Manufacturer
- Sanofi-Aventis U.S. LLC
- First approval
- 2017-03-28
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown